Related Experiment Videos
Complement 4 gene deletion in patients with IgA nephropathy and Henoch-Schönlein nephritis
1Department of Immunology, National Children's Medical Research Center, Tokyo, Japan.
Insights
Complement C4 gene deletion is linked to IgA nephropathy and Henoch-Schönlein nephritis in Japanese individuals. This finding suggests C4 gene deletion is a genetic risk factor for these kidney diseases.
Area of Science:
- Immunogenetics
- Nephrology
- Molecular Biology
Background:
- IgA nephropathy and Henoch-Schönlein nephritis have been associated with deficiencies in the fourth component of complement (C4), particularly the B isotype.
- Recent studies have questioned this association, as traditional C4 allotyping cannot distinguish C4 deficiency from C4 duplication.
Purpose of the Study:
- To investigate the association between C4 gene deletion and IgA nephropathy and Henoch-Schönlein nephritis at the DNA level.
- To clarify the role of C4 gene deletion in the pathogenesis of these kidney diseases.
Main Methods:
- Combined DNA restriction fragment length polymorphism analysis with conventional C4 allotyping.
- Assessed C4 gene deletion frequency in patients with IgA nephropathy and Henoch-Schönlein nephritis compared to controls.
Main Results:
- The frequency of C4 gene deletion was significantly increased in the patient group.
- No significant difference was observed in the frequency of C4 null phenotype between patients and controls.
- This suggests that C4 gene deletion, not necessarily a null phenotype, is elevated.
Conclusions:
- C4 gene deletion is a significant genetic risk factor for IgA nephropathy and Henoch-Schönlein nephritis, particularly in the Japanese population.
- The study highlights the importance of molecular methods for accurate genetic assessment in nephrological diseases.
Abstract:
The fourth component of complement (C4), especially B isotype, has been said to be deficient in the IgA nephropathy and Henoch-Schönlein nephritis. However, the association between these diseases and C4 deficiency was questioned recently, and the usual C4 allotyping method is unable to discriminate the C4 deficiency from the C4 duplication. So by combining the DNA restriction fragment length polymorphism with the usual C4 allotyping, we tried to determine whether the deficiency of C4 can be demonstrated in the DNA level. We found that the frequency of C4 gene deletion was increased, although the frequency of null phenotype was not different from the control. From these results we can say that C4 gene deletion is a genetic risk factor in these diseases, at least in the Japanese population.